Blood and Bleeding Disorders in Children & Adolescents
At Manning Family Children’s, our dedicated hematology team provides
comprehensive, compassionate care for children and adolescents living
with blood disorders. We offer specialized programs designed to meet the
unique needs of young patients and their families. These include the following
specialty programs:
Hemophilia, Bleeding Disorders, and Thrombosis Program - this program offers expert diagnosis, treatment, and long-term management
of clotting and bleeding disorders such as hemophilia, thrombophilia,
and platelet disorders.
Sickle Cell Disease Treatment Program – this program is focused on delivering advanced, family-centered
care for children with this complex inherited blood disorder that affects
100,000 children and adults in the United States.
Together, these programs ensure every child receives personalized, multidisciplinary
support at every stage of their journey. Our hematology service cares
for the largest group of Sickle Cell Disease patients in Louisiana, and
more children with blood disorders come to Manning Family Children's for
treatment than to any other hospital in the state. Patients receive the
highest level of care from a medical staff experienced in the latest treatments
for a full spectrum of disorders.
Manning Family Children’s is one of a select few programs nationally
to now offer both FDA-approved gene altering technologies providing gene
therapy treatment for sickle cell disease, providing patients a chance
for hope and futures restored, in collaboration with its medical school
partners, LSU Health New Orleans and Tulane University School of Medicine.
Dr. Ben Watkins, Director of the Stem Cell Transplant and Cellular Therapies
Program at Manning Family Children’s and Section Chief of Pediatric
Hematology/Oncology at Tulane Medicine, has helped develop this groundbreaking program.
Pediatric Hematology and OncologyView Profile
